Abstract: A description is given of 4-trifluoromethylpyrazolyl-substituted pyridines and pyrimidines of the formula (I) and of their use as herbicides. In this formula (I), R1, R2, R3 and R4 stand for various radicals, A for an aromatic or heteroaromatic radical, and Z denotes a nitrogen or carbon atom.

Abstract: Liquid formulations in crop protection and their use Formulations with delayed release of agrochemical actives from the group of fatty acid synthetase inhibitors are suitable for reducing phytotoxicity in crop plants when said agrochemical actives are used to check unwanted detrimental organisms in the crops.

Abstract: Dynamic mixer having at least a housing, at least two rotating agitators, at least one of the agitators being a helical or anchor agitator arranged centrally in the housing, and at least one of the other agitators being an eccentrically arranged screw or blade agitator.

Abstract: The invention relates to an optically active compound of formula (I) or a salt thereof: wherein the various symbols are as described herein, or relates to processes for their preparation, to compositions thereof, and to their use as herbicides or plant growth regulators.

Abstract: The present invention relates to an orally administrable preparation comprising a quinolone antibiotic which releases the active compound with a delay.

Abstract: A sensor dispensing instrument adapted to handle a sensor pack containing a plurality of sensors and to perform a test using one of the sensors. The sensor dispensing instrument includes an outer housing and a mechanical mechanism contained therein for rotating the sensor pack and ejecting one of the sensors from the sensor pack and through a sensor slot on the housing. The sensor dispensing instrument also includes a puller handle for operating the mechanical mechanism. The puller handle is adapted to be grasped between the thumb and finger of a user's hand, and is moveable between a testing position adjacent to the rear end of the outer housing and an extended position spaced outwardly from the rear end of the outer housing.

Abstract: The invention concerns novel enzymes having an arogenate dehydrogenase activity, in particular arogenate dehydrogenase enzymes of plants, and the genes encoding said enzymes. The inventive arogenate dehydrogenase enzymes catalyze the last stage of the metabolic pathway of tyrosine biosynthesis, and constitute, as such, potential targets of herbicides. Hence the invention also concerns a method for identifying herbicide compounds targeting said enzymes, said herbicide compounds preventing tyrosine biosynthesis by being fixed on said enzymes. The invention further concerns transgenic plants tolerant to herbicide compounds targeting an enzyme involved in the tyrosine biosynthesis pathway, in particular an enzyme involved in the transformation of L-tyrosine prephenate, in particular an arogenate dehydrogenase enzyme.

Abstract: A multi stage process for the production of polycarbonates having low monomer content is disclosed. The process entails, in sequence, (i) transesterifying in the melt at least one dihydroxyaryl compound with at least one diaryl carbonate in the presence of at least one onium catalyst to produce a polycondensate that contains monomers, (ii) introducing into the polycondensate an inhibitor in an hypostoichiometric amount in relation to the catalyst and (iii) reducing in a finishing reactor the content of monomers in said polycondensate. The polycarbonate thus produced is characterized in that it contains less than 350 ppm of diphenyl carbonate, less than 40 ppm of 2,2-bis-(4-hydroxyphenyl)propane and less than 150 ppm of phenol.

Abstract: The invention relates to novel substituted benzoylpyrazoles of the formula (I), in which n, A, R1, R2, R3, R4, Y, and Z are as defined herein, and also to processes for their preparation and to their use as herbicides.

Abstract: The invention relates to novel insecticidal active compound combinations comprising, firstly, compounds which act as insecticides on nicotinergic acetylcholine receptors as agonists and antagonists, and at least one active compound from the group of the anthranilamides, which combinations are suitable for protecting plants against attack by pests.

Abstract: The present invention relates to the combined use of substituted benzimidazoles and 1,2,4-triazine compounds against parasitic protozoa, in particular coccidia.

Abstract: The present invention relates to calix[4]arenes which effectively bind alkali metal ions (Na+, K+) and transport them over phase boundaries, their preparation and use.

Abstract: The present invention relates to compositions containing different stages of pathogenic protozoans in a gel and to their use for controlling rodents.

Abstract: The present invention relates to the use of known 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position and cGMP PDE-inhibitory properties for the production of medicaments for the treatment of cardiac insufficiency, psoriasis, female infertility, cancer, diabetes, ophthalmic disorders such as glaucoma, disorders of gastric motility, cystic fibrosis, premature labour, pulmonary hypertension, bladder disorders, prostate hyperplasia, nitrate-induced tolerance, pre-eclampsia, alopecia, Parkinson's disease, pain, tinnitus or the renal syndrome.

Abstract: The present invention relates to novel aspartates, their method of production and the use of these mono and polyaspartates as reactive components for polyisocyanates in two-component polyurethane coating compositions and for preparing polyurethane prepolymers.

Abstract: Coating compositions that are stable to thermal yellowing that include coating materials containing I) one or more dispersions of hydroxyl-free polyurethanes and/or polyurethane-ureas, II) one or more aqueous solutions or dispersions of ionically modified, hydroxyl-containing polyurethanes and/or polyurethane-ureas, other than the constituents of component I), and III) at least one crosslinker.

Abstract: A method is described for the back-moulding of sheets (7) with thermoplastics, in particular of printed sheets to protect the decorated surface against scratching or detachment, in which a sheet (7) that is initially separated from the moulded-article wall is pressed against the moulded-article wall by the melt front (3).

Abstract: Herein disclosed are methods that are prognostic for renal cell carcinoma, particularly renal clear cell carcinoma, afflicting a vertebrate. An exemplary prognostic method comprises detecting the presence of, and quantitating the level and/or extent of a MN/CA9 gene expression product in a sample from the affected subject, wherein if 50% or fewer cells are found to express the MN/CA9 gene, then the subject is considered to have a poorer prognosis. MN/CA9 gene expression products useful in the prognostic methods include MN protein, MN polypeptide and/or MN nucleic acids. The methods are useful as an aid in the selection of treatment for a patient with renal cell carcinoma, alone or in combination with conventional tumor stage and/or grade information. The methods of the invention can be used, for example, to identify those patients requiring more aggressive therapy regimens, or those patients most likely to respond to adjuvant immunotherapies, particularly MN/CA IX/CA9-targeted therapies.

Abstract: The invention relates to novel 2-halo-6-alkylphenyl-substituted spirocyclic tetramic acid derivatives of the formula (I) in which A, B, D, G, X, Y and Z are as defined above, to a plurality of processes and intermediates for their preparation and to their use as pesticides and/or herbicides, and also to selective herbicidal compositions comprising firstly the 2-halo-6-alkylphenyl-substituted spirocyclic tetramic acid derivatives of the formula (I) and secondly at least one crop plant compatibility-improving compound.

Abstract: A combination product which comprises as pharmaceutically active ingredients at least one active ingredient component A and at least one active ingredient component B, where active ingredient component A is a direct soluble guanylate cyclase stimulator of the formula (I) and active ingredient component B is a lipid-lowering agent, is described and claimed. Methods for treating various conditions using combination therapy are also claimed.